UCL logo

UCL Discovery

UCL home » Library Services » Electronic resources » UCL Discovery

Reversible Keap1 inhibitors are preferential pharmacological tools to modulate cellular mitophagy

Georgakopoulos, ND; Frison, M; Alvarez, MS; Bertrand, H; Wells, G; Campanella, M; (2017) Reversible Keap1 inhibitors are preferential pharmacological tools to modulate cellular mitophagy. Scientific Reports , 7 , Article 10303. 10.1038/s41598-017-07679-7. Green open access

Text (Version of record)
s41598-017-07679-7.pdf - ["content_typename_Published version" not defined]

Download (2MB) | Preview
Text (Supplementary figures)

Download (967kB) | Preview


Mitophagy orchestrates the autophagic degradation of dysfunctional mitochondria preventing their pathological accumulation and contributing to cellular homeostasis. We previously identified a novel chemical tool (hereafter referred to as PMI), which drives mitochondria into autophagy without collapsing their membrane potential (ΔΨm). PMI is an inhibitor of the protein-protein interaction (PPI) between the transcription factor Nrf2 and its negative regulator, Keap1 and is able to up-regulate the expression of autophagy-associated proteins, including p62/SQSTM1. Here we show that PMI promotes mitochondrial respiration, leading to a superoxide-dependent activation of mitophagy. Structurally distinct Keap1-Nrf2 PPI inhibitors promote mitochondrial turnover, while covalent Keap1 modifiers, including sulforaphane (SFN) and dimethyl fumarate (DMF), are unable to induce a similar response. Additionally, we demonstrate that SFN reverses the effects of PMI in co-treated cells by reducing the accumulation of p62 in mitochondria and subsequently limiting their autophagic degradation. This study highlights the unique features of Keap1-Nrf2 PPI inhibitors as inducers of mitophagy and their potential as pharmacological agents for the treatment of pathological conditions characterized by impaired mitochondrial quality control.

Type: Article
Title: Reversible Keap1 inhibitors are preferential pharmacological tools to modulate cellular mitophagy
Location: England
Open access status: An open access version is available from UCL Discovery
DOI: 10.1038/s41598-017-07679-7
Publisher version: http://dx.doi.org/10.1038/s41598-017-07679-7
Language: English
Additional information: Copyright © The Author(s) 2017. Open Access: This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
Keywords: Mitophagy, Small molecules
URI: http://discovery.ucl.ac.uk/id/eprint/1573335
Downloads since deposit
Download activity - last month
Download activity - last 12 months
Downloads by country - last 12 months

Archive Staff Only

View Item View Item